Literature DB >> 15609223

How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners.

Pam Sonnenberg1, Judith R Glynn, Katherine Fielding, Jill Murray, Peter Godfrey-Faussett, Stuart Shearer.   

Abstract

BACKGROUND: Infection with human immunodeficiency virus (HIV) increases the risk of tuberculosis (TB), but no study has assessed how this risk changes with time since HIV seroconversion.
METHODS: The incidence of pulmonary TB was estimated in miners with and those without HIV infection in a retrospective cohort study. HIV test results were linked to routinely collected TB, demographic, and occupational data. The rate ratio (RR) for the association between HIV status and TB was estimated by time since HIV seroconversion, calendar period, and age.
RESULTS: Of the 23,874 miners in the cohort, 17,766 were HIV negative on entry, 3371 were HIV positive on entry, and 2737 seroconverted during follow-up (1962 had a seroconversion interval of < or =2 years). A total of 740 cases of TB were analyzed. The incidence of TB increased with time since seroconversion, calendar period, and age. TB incidence was 2.90 cases/100 person-years at risk (pyar) in HIV-positive miners and was 0.80 cases/100 pyar in HIV-negative miners (adjusted RR, 2.9 [95% confidence interval {CI}, 2.5-3.4]). TB incidence doubled within the first year of HIV infection (adjusted RR, 2.1 [95% CI, 1.4-3.1]), with a further slight increase in HIV-positive miners for longer periods, up to 7 years.
CONCLUSION: The increase in the risk of TB so soon after infection with HIV was unexpected. Current predictive models of TB incidence underestimate the effect of HIV infection in areas where TB is endemic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15609223     DOI: 10.1086/426827

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  149 in total

1.  Mining and risk of tuberculosis in sub-Saharan Africa.

Authors:  David Stuckler; Sanjay Basu; Martin McKee; Mark Lurie
Journal:  Am J Public Health       Date:  2010-06-01       Impact factor: 9.308

Review 2.  Tuberculosis and HIV Coinfection.

Authors:  Judith Bruchfeld; Margarida Correia-Neves; Gunilla Källenius
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-26       Impact factor: 6.915

3.  Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?

Authors:  S D Lawn; A D Harries; B G Williams; R E Chaisson; E Losina; K M De Cock; R Wood
Journal:  Int J Tuberc Lung Dis       Date:  2011-05       Impact factor: 2.373

4.  New methods for estimating the tuberculosis case detection rate in high-HIV prevalence countries: the example of Kenya.

Authors:  John Mansoer; Suzanne Scheele; Katherine Floyd; Christopher Dye; Joseph Sitienei; Brian Williams
Journal:  Bull World Health Organ       Date:  2009-03       Impact factor: 9.408

Review 5.  Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD.

Authors:  R N van Zyl Smit; M Pai; W W Yew; C C Leung; A Zumla; E D Bateman; K Dheda
Journal:  Eur Respir J       Date:  2010-01       Impact factor: 16.671

6.  HIV-1 and the immune response to TB.

Authors:  Naomi F Walker; Graeme Meintjes; Robert J Wilkinson
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

7.  Lower levels of interleukin-12 precede the development of tuberculosis among HIV-infected women.

Authors:  José Bordón; Michael W Plankey; Mary Young; Ruth M Greenblatt; Maria C Villacres; Audrey L French; Jie Zhang; Guy Brock; Savitri Appana; Betsy Herold; Helen Durkin; Jonathan E Golub; Rafael Fernandez-Botran
Journal:  Cytokine       Date:  2011-08-30       Impact factor: 3.861

8.  Distinct gene-expression profiles associated with the susceptibility of pathogen-specific CD4 T cells to HIV-1 infection.

Authors:  Haitao Hu; Martin Nau; Phil Ehrenberg; Agnes-Laurence Chenine; Camila Macedo; Yu Zhou; Z John Daye; Zhi Wei; Maryanne Vahey; Nelson L Michael; Jerome H Kim; Mary Marovich; Silvia Ratto-Kim
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

9.  Coinfection of Tuberculosis in an Undiagnosed HIV, AIDS Patient Presenting With Shortness of Breath, Constitutional Symptoms and Lymphadenopathy.

Authors:  Mirian V Garcia Rivera; Angel Aponte; War War Ko
Journal:  Cureus       Date:  2021-06-25

10.  Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children.

Authors:  Andrew Edmonds; Jean Lusiama; Sonia Napravnik; Faustin Kitetele; Annelies Van Rie; Frieda Behets
Journal:  Int J Epidemiol       Date:  2009-05-15       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.